National Comprehensive Cancer Network

Home | About NCCN | Find a Member Institution | Login/Register | Contact Us

Members Only

NCCN Oncology Research Program (ORP)

NCCN ORP Recent News

NCCN ORP Affiliate Research Project

NCCN ORP Scientific Publications

NCCN ORP for Industry

NCCN ORP Investigator Steering Committee

NCCN ORP Testimonials

NCCN Clinical Trials at NCCN Member Institutions

Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions

NCCN Informed Consent Language Database

NCCN Specialized Imaging Research Consortium™ (SIRC)

NCCN ORP Disclosure Policy

NCCN Insights: Analytics, Research & Consulting

NCCN Flash Updates™

NCCN Oncology Insights Reports™

NCCN Oncology Outcomes Database

NCCN Trends™ Surveys & Data

NCCN Trends™ International Surveys

NCCN Collaboration with the National Business Group on Health

Executive Summary

Tool 1: Quick Reference Guide and Assessment

Tool 2: Plan Design and Assessment Tool

Tool 3, Part I: Request for Proposal (RFP) Questions and Requested Evidence for Vendors

Tool 3, Part II: Request for Proposal (RFP) and Response Evaluation for Employers

Tool 3, Part III: RFP and Vendor Scoring

Tool 4: Summary Plan Description (SPD) Guidance

Tool 5: Vendor Contracting and Administration

Tool 6: Evaluation and Plan Reporting

NCCN Resource Tool: REMS

NCCN Virtual Reimbursement Resource Room

NCCN Best Practices

NCCN Health Information Technology Licensees

NCCN Firewall Policy

NCCN Embargo Policy

Read about NCCN Member Institutions in the U.S. News Best Hospitals Guide Ad

Supporter Opportunities

NCCN Research & Business Resources

Stanford Cancer Institute
Stanford, CA
877.668.7535
http://cancer.stanford.edu

Learn more about clinical trials at this NCCN Member Institution.

Profile

Stanford University is an international leader in cancer research and patient care. The mission of the Stanford Clinical Cancer Program is to provide comprehensive care through multidisciplinary collaboration and integrated services, to advance cancer therapies through clinical research, and to train future leaders in the treatment of patients with cancer. The collaborative approach to cancer research and treatment is a hallmark of this program. Surgeons, medical oncologists, radiation oncologists, pediatric oncologists, radiologists, and pathologists participate in sixteen weekly combined modality clinics.

The Clinical Cancer Program at Stanford is comprehensive. Highlights include:

• Translational research and innovative combined modality trials for management of cancers of the prostate, head and neck, breast, lung, colon, liver, melanoma, and other solid tumors.

• Pioneering efforts in the management of Hodgkin's disease and the lymphomas.

• Premier bone marrow transplantation.

• Highly advanced radiation therapy techniques including conformal radiotherapy, intraoperative radiotherapy, high-dose-rate brachytherapy, intravascular brachytherapy, stereotactic radiotherapy, and radio-immunotherapy.

• Specialized therapy for AIDS-related malignancies.

• World-renowned neuro-oncology program providing innovative therapy for brain and spinal cord cancers.

• Risk prevention/genetic screening.

• Leaders in the treatment of pediatric malignancies, particularly lymphomas and sarcomas.

One hundred and sixty faculty members participate in cancer care and clinical research with over 500 active clinical trials. Research on the fundamentals of cancer is conducted in the Center for Molecular and Genetic Medicine and the Center for Clinical Sciences Research.